These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Comparison of AIK-C measles vaccine in infants at 6 months with Schwarz vaccine at 9 months: a randomized controlled trial in Ghana. Nkrumah FK, Osei-Kwasi M, Dunyo SK, Koram KA, Afari EA. Bull World Health Organ; 1998; 76(4):353-9. PubMed ID: 9803586 [Abstract] [Full Text] [Related]
23. Development of a measles vaccine production process in MRC-5 cells grown on Cytodex1 microcarriers and in a stirred bioreactor. Trabelsi K, Majoul S, Rourou S, Kallel H. Appl Microbiol Biotechnol; 2012 Feb; 93(3):1031-40. PubMed ID: 21935589 [Abstract] [Full Text] [Related]
27. Effect of some factors on the biological activity of measles virus. Horváth LB. Acta Microbiol Acad Sci Hung; 1973 Feb; 20(2):83-8. PubMed ID: 4204477 [No Abstract] [Full Text] [Related]
28. Measles virus mutants and their implications in basic and applied virology. Makino S. Ann Microbiol (Paris); 1977 Feb; 128B(4):507-15. PubMed ID: 565182 [No Abstract] [Full Text] [Related]
31. Role of normal cell antigens in the establishment of measles virus in newborn white mice. Karaseva IA, Khozinsky VI, Chumakov MP. Acta Virol; 1977 Mar; 21(2):170-2. PubMed ID: 17289 [Abstract] [Full Text] [Related]
33. Approaches to attenuation of an autochthonous measles virus strain. Cernescu C, Cajal N, Cepleanu M, Sorodoc Y. Rev Roum Virol (1972); 1973 Mar; 10(2):117-26. PubMed ID: 4724473 [No Abstract] [Full Text] [Related]
34. Sensitization of guinea-pigs to measles vaccines. Aprile MA, Kadar D, Wilson S. Clin Exp Immunol; 1969 Nov; 5(5):531-9. PubMed ID: 4982816 [Abstract] [Full Text] [Related]
35. [Clinical reactions and antibody responses of measles-susceptible healthy children to the live measles "AIK-C" vaccine(chick embryo tissue culture type)]. Okayama T. Kansenshogaku Zasshi; 1975 Apr; 49(4):150-8. PubMed ID: 811729 [No Abstract] [Full Text] [Related]
36. Temperature-dependent growth restriction in measles vaccine strains. Fukuda A, Sugiura A. Jpn J Med Sci Biol; 1983 Dec; 36(6):331-5. PubMed ID: 6676504 [Abstract] [Full Text] [Related]
37. Studies on further attenuated live measles vaccine. 3. Selection of less reactive variants of CAM measles vaccine virus. Takaku K, Sasada T, Konobe T, Onishi K, Ueda S. Biken J; 1970 Sep; 13(3):163-8. PubMed ID: 5530510 [No Abstract] [Full Text] [Related]
38. Studies on further attenuated live measles vaccine. IV. Clinical and serological evaluation of a clone of CAM-CEF measles vaccine virus. Ueda S, Takahashi M, Kurimura T, Ogino T, Suzuki N. Biken J; 1970 Sep; 13(3):169-74. PubMed ID: 5530511 [No Abstract] [Full Text] [Related]
39. Leucine at position 278 of the AIK-C measles virus vaccine strain fusion protein is responsible for reduced syncytium formation. Nakayama T, Komase K, Uzuka R, Hoshi A, Okafuji T. J Gen Virol; 2001 Sep; 82(Pt 9):2143-2150. PubMed ID: 11514723 [Abstract] [Full Text] [Related]
40. Live measles vaccine prepared in dog kidney cells. 3. Vaccination against measles with Czechoslovak live vaccine. Adam E, Kratochvílova M, Mares I, Drevo M, Závadová H. J Hyg Epidemiol Microbiol Immunol; 1966 Sep; 10(2):232-9. PubMed ID: 5330077 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]